Patient Capital Management, LLC Karuna Therapeutics, Inc. Transaction History

Patient Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$161.01 - $317.85 $26.5 Million - $52.3 Million	-164,621 Reduced 93.4%	11,631 $3.68 Million
Q3 2023 Nov 14, 2023	SELL	$164.66 - $218.08 $94,514 - $125,177	-574 Reduced 0.32%	176,252 $29.8 Million
Q2 2023 Aug 14, 2023	BUY	$176.32 - $240.22 $27.1 Million - $36.9 Million	153,451 Added 656.47%	176,826 $38.3 Million
Q1 2023 May 15, 2023	BUY	$161.33 - $204.36 $915,547 - $1.16 Million	5,675 Added 32.06%	23,375 $4.25 Million
Q3 2022 Nov 14, 2022	SELL	$123.79 - $277.42 $198,064 - $443,872	-1,600 Reduced 8.29%	17,700 $3.98 Million
Q2 2022 Aug 15, 2022	BUY	$93.97 - $143.33 $140,955 - $214,995	1,500 Added 8.43%	19,300 $2.44 Million
Q1 2022 May 16, 2022	SELL	$98.9 - $132.37 $138,460 - $185,318	-1,400 Reduced 7.29%	17,800 $2.26 Million
Q4 2021 Feb 14, 2022	BUY	$110.64 - $159.4 $2.12 Million - $3.06 Million	19,200 New	19,200 $2.52 Million

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Patient Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Patient Capital Management, LLC with notifications on news.